Moreover, we found that the expression level of TFRC in AML patient-derived leukemia cells did not show a significant difference from AML cells with the different expression levels of GPR56 or CD34 (GSE129094, Additional file 1: Fig. S5a). The gene discussed is CD34; the disease is acute myeloid leukemia.